| __timestamp | BioMarin Pharmaceutical Inc. | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 55402000 |
| Thursday, January 1, 2015 | 737887000 | 66107000 |
| Friday, January 1, 2016 | 907234000 | 103402000 |
| Sunday, January 1, 2017 | 1071860000 | 135736000 |
| Monday, January 1, 2018 | 1175948000 | 245116000 |
| Tuesday, January 1, 2019 | 1344582000 | 108935000 |
| Wednesday, January 1, 2020 | 1336183000 | 156000000 |
| Friday, January 1, 2021 | 1375760000 | 214957000 |
| Saturday, January 1, 2022 | 1612370000 | 143418000 |
| Sunday, January 1, 2023 | 1842161000 | 96265000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated have showcased distinct trajectories in gross profit over the past decade. From 2014 to 2023, BioMarin's gross profit surged by nearly 200%, reflecting its robust growth and strategic advancements in the pharmaceutical sector. In contrast, Ligand Pharmaceuticals, while experiencing fluctuations, managed a commendable increase of approximately 74% during the same period.
BioMarin's consistent upward trend, peaking in 2023, underscores its successful product pipeline and market expansion strategies. Meanwhile, Ligand's performance, with notable peaks in 2018 and 2021, highlights its resilience and adaptability in a dynamic market. This comparative analysis not only provides insights into the financial health of these companies but also serves as a testament to the evolving nature of the biotech industry, where innovation and strategic foresight are key to sustained profitability.
Gross Profit Comparison: Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated Trends
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Analysis: Comparing Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Viatris Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Trends Compared: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
Key Insights on Gross Profit: Ascendis Pharma A/S vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Ligand Pharmaceuticals Incorporated
MorphoSys AG and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated